ArticleEuropean journal of clinical investigation2026
Systemic Inflammation and Risk of Thromboembolism, Mortality, and Treatment Response in Patients With Cancer Receiving Immune Checkpoint Inhibitors.
Leyla Ay et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.